Gawande argues that a key responsibility of clinicians is to help terminally ill people and families find the courage to navigate the uncharted waters of critical illness and dying well. This means:
- Initiating candid discussions about what to expect as disease progresses
- Providing information, experience, and recommendations to guide difficult choices
- Eliciting goals, priorities, and wishes along with the medical details
- Acknowledging emotions and existential concerns in addition to bodily ones
- Affirming the patient's continuing value and the importance of their priorities
- Marshaling resources to help them achieve meaningful aims with the time that remains
In short, it means being an "expert guide and partner" in shaping the end of life, not just the illness. Defaulting to medical solutions neglects the fuller, harder human needs at this juncture.
Section: 1, Chapter: 8
In the introduction, Gawande laments that medical training taught him little about aging, death and how to help patients navigate the final phases of life. The medical system is geared toward trying to fix health problems, often without appreciating the limits of what doctors can do for elderly, frail patients facing mortality. As people live longer, doctors are often ill-equipped to improve the quality of their patients' waning days.
Section: 1, Chapter: 1
In Chapter 3, Gawande traces the history of nursing homes, which arose as hospitals became unable to house elderly patients needing an institutional level of care. However, rather than being designed to optimize quality of life, nursing homes were modeled on hospitals and operated according to priorities of safety, efficiency and convenience for staff. They become "total institutions" that rob residents of privacy, autonomy and connections to the outside world. Even as conditions have improved, nursing homes remain woefully inadequate in meeting the full range of social and emotional needs of the elderly.
Section: 1, Chapter: 3
"Our most cruel failure in how we treat the sick and aged is the failure to recognize that they have priorities beyond merely being safe and living longer."
Section: 1, Chapter: 6
Gawande cites research showing that terminally ill patients tend to care less about survival and other traditional medical priorities than about:
- Avoiding suffering
- Strengthening relationships with family and friends
- Maintaining dignity and control over daily life
- Having a sense that their life is complete
But these priorities often go unspoken in a system focused on beating disease. Even facing certain death, only a third of terminal cancer patients report end-of-life discussions with doctors. As a result:
- 40% get chemotherapy in their last two weeks, usually with little benefit
- Two-thirds never enter hospice care or only in the last few days
- Half die in hospitals or nursing homes, often tethered to machines, in pain, with family unprepared
Patients need guidance weighing not just medical options but existential ones, while still supporting their need for hope.
Section: 1, Chapter: 6
"We imagine our job is to ensure health and survival. But really it is larger than that. It is to enable well-being."
Gawande argues that the job of doctors is more than just ensuring health and survival - it's enabling overall well-being, especially at the end of life. This requires understanding patients' priorities beyond just living longer and working to achieve what matters most to them.
Section: 1, Chapter: 1
All I can think of
Is that I am lying
In a house in the snow.
- Masaoka Shiki
Section: 2, Chapter: 6
We see the profound shift from an inherited disease of intellect to a contracted disease of filth in the racialization of tuberculosis. As late as 1880, white American physicians still argued that consumption did not occur among Black Americans, who, it was claimed, lacked the intellectual superiority and calm temperament to be affected by the White Plague. But after Koch identified Mycobacterium tuberculosis in 1882, all that changed.
Racialized medicine no longer maintained that high rates of consumption among white people was a sign of white superiority; instead, racialized medicine maintained that high rates of consumption among Black people was a sign of white superiority. One white doctor's 1896 treatise asserted that African Americans were disproportionately dying of tuberculosis due to their smaller chest capacity and increased rate of respiration.
Section: 3, Chapter: 9
One day, young Gale overheard a terrible secret about her best friend Angie: Angie's sister Pauline, who wrote her weekly, had in fact already died of TB. "But her father didn't want her to know," Gale recalled, because it might cause the kind of emotional shock that was deemed dangerous to the TB patient. So to encourage the daughter he still had, this father wrote letters that mimicked the handwriting and style of the daughter he'd lost.
Having been told that patients could not be exposed to bad news without risking their health, Gale never told Angie that her sister had died. But it didn't matter. "I saw them wheeling a stretcher with a body on it down to the morgue. I knew right away it was my best friend Angie." Gale was eight years old.
Section: 3, Chapter: 11
Gale was just three years old when she arrived at Lakeville Sanatorium in Massachusetts, and like many patients, she was told that a positive attitude and absolute fealty to her physician's treatment plan were essential to her survival. She recalled, "The night was frightening to me—the darkness would start to settle in, then the stillness. The children sobbed, calling for their mothers. The nurses would come in and say, 'Silence, everyone!'"
At many institutions, crying in public was strictly forbidden, because it would harm morale and thus one's overall chance for a cure. For young Gale, visitors were very rare, and she was frequently chastised for her bad attitude and behavior. "Punishment consisted of being isolated," she wrote. "No one could talk to me; I could not play with any of my toys; a screen would be placed around my bed so I could not see the rest of the children." This happened when she was just four years old.
Section: 3, Chapter: 11
Antibiotic resistance is a complex and many-tentacled beast—countless factors from overprescription to antibiotic use in livestock have contributed to it. But in considering the rise of multidrug-resistant tuberculosis in particular, it's important to note that we are in this mess first and foremost because we stopped trying to develop new treatments for tuberculosis. The real issue is not that TB is uncommonly good at selecting for resistance. The real problem is that in the forty-six years between 1966 and 2012, we developed no new drugs to treat tuberculosis.
In the last couple decades as economic incentives have shifted, we've been able to develop powerful new medications to treat TB, including bedaquiline and delamanid. When markets tell companies it's more valuable to develop drugs that lengthen eyelashes than to develop drugs that treat malaria or tuberculosis, something is clearly wrong with the incentive structure.
Section: 4, Chapter: 14
Analyses of cost-effectiveness often only run skin deep. When looking at the larger costs—the cost of the ineffective pills, the cost of potentially further spreading drug-resistant TB, the cost of hospitalizing a kid who should've been in school, and all the other costs of not getting kids access to proper testing—GeneXpert tests should be in every clinic in every country with a high burden of TB.
From that perspective, investing in tuberculosis diagnosis and treatment begins to look like one of the best bets in global health. A 2024 study commissioned by the WHO found that every dollar spent on tuberculosis care generates around thirty-nine dollars in benefit by reducing the number (and expense) of future TB cases, and through more people being able to work rather than being chronically ill or caring for their chronically ill loved ones.
Section: 4, Chapter: 15
When I began reading and writing about tuberculosis, I was very fortunate to come across Vidya Krishnan's arresting and brilliant book Phantom Plague: How Tuberculosis Shaped History. She describes what Dr. Carole Mitnick calls "a failure of imagination." "There is this continued mentality of scarcity in TB," she explained.
I think of this in the context of my brother Hank and his cancer care. No one questioned whether treating my brother's lymphoma was "cost-effective," even though it cost a hundred times more than it would've to cure Henry's tuberculosis. I would never accept a world where Hank might be told, "I'm sorry, but while your cancer has a 92 percent cure rate when treated properly, there just aren't adequate resources in the world to make that treatment available to you." How can I accept a world where Henry and his family are told that?
Section: 5, Chapter: 18
Beginning in the early 1980s, physicians and activists in the Global South began sounding the alarm about an explosion in uncommonly swift and severe cases of tuberculosis. Young patients were dying within weeks instead of over years, often with TB disseminating throughout their lungs with terrifying speed, choking patients to death.
These deaths seemed to be associated with the emerging pandemic now known as HIV/AIDS. In 1985, physicians noted high rates of active tuberculosis disease among HIV-positive patients in Zaire and Zambia. Because untreated HIV lowers resistance to infection, TB infections are far more likely to progress to active disease as the immune system weakens, and that weakened immune system allows TB to kill quickly. Even though many were pointing out this connection, far too little was done to expand access either to TB or HIV medication in low- and middle-income countries.
Section: 5, Chapter: 19
Within a week of the new medication regimen, Dr. Girum noticed progress, especially with the open sores from Henry's ruptured lymph nodes. "It was like magic," he told me. For over a month, Henry had lived with open wounds in his neck and shoulder from lymph nodes so swollen they burst through the skin. But now, the nodes were retreating, and the open sores began to heal. "I could see the wound drying," Dr. Girum said. "I told myself, 'This is an early sign.' In a week, the boy started to eat well."
After a few months of effective treatment, no bacteria was detectable in Henry's sputum for the first time in years. Although the infection still lived in his lungs and lymph, he was far less infectious, and so he was able to receive visitors again. Isatu returned to her daily visits.
Section: 6, Chapter: 21
Phumeza Tisile, a TB survivor, along with her friend and fellow TB survivor Nandita Venkatesan, filed a patent challenge in an Indian court asking the government to reject efforts by the pharmaceutical company Johnson & Johnson to extend their patent on the drug bedaquiline.
Bedaquiline is a powerful medicine in the fight against MDR-TB, but was far out of reach for most people living with the disease, because J&J charged $900 for a single course of treatment in poor countries and $3,000 in middle-income countries. After negotiations and protests, J&J backed down, allowing generic bedaquiline in most countries. As a direct result, the price of bedaquiline dropped by over 60 percent almost overnight.
Section: 6, Chapter: 22
TB activists and researchers have developed a comprehensive plan—and yes, of course it has an acronym: STP (Search, Treat, Prevent). The STP initiative would hire healthcare workers to Search for cases household by household around the world, diagnosing cases of TB before they become so serious or disabling as to require hospitalization. It would then Treat those diagnosed with a four-month course of antibiotics for most patients, and a six-month course for those with multidrug-resistant TB. And lastly, this program would Prevent further lines of infection by offering one month of preventive therapy to all those living in the same household as a person diagnosed with TB, because that preventive therapy helps to end the chain of transmission.
If we spent twenty-five billion dollars on comprehensive care per year, we could drive tuberculosis toward elimination. We'd also save a lot of money in the long run—over forty dollars for each of those twenty-five billion dollars.
Section: 6, Chapter: 23
We can understand the history of tuberculosis as a story of competing paradigms: These days, we primarily see tuberculosis through a biomedical lens—as an infection caused by a bacterium and cured by drugs designed to kill or otherwise inhibit that bacterium. Others view TB through a religious paradigm or a hereditary one or a sociological lens, as an illness caused by poverty and marginalization.
The biomedical paradigm has become so powerful in my imagination that it's easy to forget how inadequate mere medicine can be. Yes, illness is a breakdown, failure, or invasion of the body treated by medical professionals with drugs, surgeries, and other interventions. But it is also a breakdown and failure of our social order, an invasion of injustice. The "social determinants of health" cannot be viewed independently of the "healthcare system," because they are essential facets of healthcare.
Section: 6, Chapter: 23
KJ Seung: Of the 1,300,000 people who will die of TB this year, how many would survive if they had access to the kind of healthcare I have?
"How many would die if everyone could access good healthcare?" he asked me, as if he seemed confused by my question.
"Yes," I said.
"None. Zero. Zero people should die of TB."
- John Green
Section: 6, Chapter: 23
Women with consumption were believed to become more beautiful, ethereal, and wondrously pure. As Charlotte Brontë put it in a letter she wrote as her sister was dying of the disease, "Consumption, I am aware, is a flattering malady."
- John Green
Section: 2, Chapter: 7
As Frank M. Snowden observes in Epidemics and Society, white physicians in Europe and the U.S. generally agreed that consumption was, as some eighteenth-century observers put it, a disease of civilization. Everyone knew that rural communities were less vulnerable to consumption. But in a highly racialized social order, conceiving of phthisis as a "civilized" disease also meant that it could not be a disease of uncivilized people, which furthered the racialization of consumption.
In Europe and the U.S., most white doctors believed that phthisis—as it was inherited by those with great sensitivity and intelligence—could only affect white people, and it was sometimes known as "The White Man's Plague." One American doctor, for instance, called it, "a disease of the master race not of the slave race." This phenomenon extended to all colonial empires. Many European colonialists believed that TB did not exist in South Asia or Africa, even though physicians working in colonized communities knew otherwise.
Section: 2, Chapter: 7
By the end of the nineteenth century, the replication and acceptance of Robert Koch's research meant that the era of consumption, an inherited condition that grew the soul by shrinking the body, ceased to exist. The era of tuberculosis, an infectious disease of the poor and marginalized, had commenced.
In fact, the way we understood "consumption"—that bright, mild, kind disease that Harriet Beecher Stowe described—was so different from the way we understood "tuberculosis" that even though they are the same disease, one could be forgiven for thinking they were entirely different. Consumption, after all, was a flattering malady, a genetic disorder enriching the soul even as it slowly destroyed the body. Tuberculosis was a horror, an invisible contamination proliferating within you and then spreading to anyone near you.
Section: 3, Chapter: 8
In the late 1990s, Partners In Health began to treat MDR-TB patients in an impoverished neighborhood of Lima where the disease had become endemic. They individually tailored treatment regimens to patients and provided comprehensive support via direct financial payments so that patients could eat enough to fuel their recovery. The project also provided regular visits from community health workers who lived in the affected communities and served as a bridge between the healthcare system and neighborhoods that had long been overlooked.
The idea was simple. "We should treat people if we have the technology," as Dr. Farmer put it. Partners In Health announced its extraordinary results: Over 85 percent of the Peruvian MDR-TB patients achieved cure with comprehensive support. One expert called it "astonishing." These cure rates were comparable to, or even better than, those seen in the world's best-funded hospitals.
Section: 6, Chapter: 22
In the eighteenth and nineteenth centuries, Europeans came to romanticize consumption, to see the illness as beautiful and ennobling. I would argue that the proper way to understand the utterly surreal romanticization of TB is that as the disease exploded in cities, stigma alone simply could not answer the "why, why, why" of consumption. Instead, people began to conclude that consumption was caused by a personality especially attuned to the fragile and fleeting loveliness of life.
This romanticization continued for a very long time: In the 1909 book Tuberculosis and the Creative Mind, Dr. Arthur Jacobson maintained that TB offered a "divine compensation" in exchange for illness: TB patients' lives "are shortened, physically, but quickened psychically in a ratio inversely as the shortening." Maybe the nineteenth-century Romantics would die early, but oh, the poems they would write.
Section: 2, Chapter: 6
Of his time at Lakka, Henry wrote in his memoir, "Every morning at the break of dawn, the nurses would arrive with a tray of medications, a bitter reminder of the battle within. These pills, each with its own set of side effects, were ingested with a mix of trepidation and hope."
- John Green
Section: 3, Chapter: 11
Henry described "a sense of interminable monotony" at Lakka, and in that way it was similar to life in sanatoria, which tended to be excruciatingly dull for the patient. The job of the "invalid," as patients were commonly known, was to improve their health. The word "invalid," of course, gets at the core of what it meant to live with chronic illness—you were a person outside of society, invalid in the social order, separated from your family and your community.
Patients were often told to move very little, discouraged even from writing letters or combing their own hair. They were also told not to feel too intensely, or drink alcohol, or have sex—all exciting behaviors that could excite the tuberculosis within. In order to maximize the chance for a cure, one doctor wrote, "The smallest details of the patient's life are controlled by the supervising physician and nothing of any importance is left to [the patient's] judgment."
Section: 3, Chapter: 11
A major component of the DOTS (Directly Observed Therapy, Short-Course) protocol was that patients would be "directly observed" taking their medication each day by someone other than a family member. Often, this means patients have to make their way to a clinic each day in order to receive their medication and be observed while swallowing the pills to ensure compliance.
It's very common to hear that one of the biggest drivers of drug resistance is patients "failing to take their meds." This so-called "patient noncompliance" is indeed a central factor driving antibiotic resistance to tuberculosis. For a variety of reasons, many patients struggle to complete their lengthy antibiotic regimens, thereby giving the infection more opportunities to evolve resistance to treatment. When I asked TB expert Dr. Jennifer Furin about this protocol and forcing people to be visually observed taking their pills each day, she told me, "I know of no other field of medicine where therapy is based so completely on lack of trust toward patients."
Section: 4, Chapter: 13
Dr. Girum was afraid—he was new to the country and didn't yet speak fluent Krio. Henry's father announced he would come back tomorrow to take his son so that Henry could spend his final days at home surrounded by those who loved him, and if he wasn't allowed to take his son, Henry's father promised to beat Dr. Girum.
The next morning, Henry's father returned to the hospital. He walked around the doctor's desk, ready to punch Dr. Girum, who calmly told Henry's father, "If you take your boy away now, all the work we have done is meaningless. I know you are a dad. I am also a dad. But I am his doctor, and I can promise you that if this boy is not doing well on a new drug regimen, come and beat me. Don't hit me today. Beat me later if this fails."
Section: 5, Chapter: 17
Tuberculosis is so often, and in so many ways, a disease of vicious cycles: It's an illness of poverty that worsens poverty. It's an illness that worsens other illnesses—from HIV to diabetes. It's an illness of weak healthcare systems that weakens healthcare systems. It's an illness of malnutrition that worsens malnutrition. And it's an illness of the stigmatized that worsens stigmatization.
In the face of all this, it's easy to despair. TB doesn't just flow through the meandering river of injustice; TB broadens and deepens that river.
Section: 5, Chapter: 19
"The issue, I think, and why confusion is the norm is that the procedures and medications that we use to treat pregnancy loss or miscarriage or fetal loss that someone did not choose are the same as treatments and medications that we use to treat and provide abortion care—which in this case means a pregnancy that ends because someone makes a decision to end it." - Dr. Lisa Harris, ob-gyn and miscarriage specialist
Many patients are shocked to learn the same pills and procedures are used for voluntary abortion and miscarriage. Heartbeat bills, which ban abortion after electrical cardiac activity is detected (around 6 weeks), make no exception for pregnancies that are already miscarrying with a doomed "heartbeat." This forces patients to carry dead or dying tissue, risks sepsis, and shatters trust that doctors are making decisions based on medical best practices rather than shifting political winds.
Section: 3, Chapter: 10
Routine ultrasounds, available since the 1980s, have allowed parents to "meet" their babies earlier than ever before. However, their cultural impact has been mixed.
Ultrasounds operate in both medical and emotional registers simultaneously. They can bring joy or grief, provide vital diagnostic information or be used as political theater (as with pre-abortion "heartbeat checks"). They complicate our understanding of life before birth.
Section: 1, Chapter: 5
In states with strict abortion bans post-Roe, medical professionals are struggling to navigate vague legal language and provide appropriate care without risking their licenses or freedom. Common dilemmas include:
- When a pregnancy complication becomes "life-threatening" enough to allow termination
- Whether mental health crises like suicidality qualify for health exceptions
- How imminent the risk of death or disability must be to avoid prosecution
- Lack of clear definitions around terms like "abortion" vs "miscarriage management"
Doctors report delaying care, avoiding certain procedures, or sending patients out of state rather than risk a felony charge. Hospital lawyers have become de facto consultants on routine OB-GYN decisions. Politicians without medical expertise are setting unworkable standards that put pregnant people in danger.
Section: 3, Chapter: 10
In the 1840s, Dr. Marion Sims, the "father of gynecology," performed experimental fistula surgeries on enslaved women without anesthesia. One 17-year-old girl, Anarcha, endured 30 surgeries over 4 years. Sims subscribed to the racist belief that Black people didn't feel pain like white people. He later experimented on poor Irish immigrants. The field of gynecology was built on the bodies of society's most vulnerable women, a legacy that continues to impact care disparities today.
Section: 1, Chapter: 2
In the mid-1800s, miscarriages started shifting from a private event managed at home to a medical issue as more poor women delivered in charity hospitals. Fetal specimens collected from these losses were displayed in doctor's offices as proof of their scientific prowess, in contrast to midwives. This "medicalization of miscarriage" coincided with:
- Advancing fields of embryology and anatomy
- Proliferation of all-male medical schools needing cadavers
- Campaigns to outlaw midwifery and abortion
- Nativist fears about falling white birth rates
Women's personal experiences, as revealed in diaries, showed a range of emotions from relief to grief. The notion of miscarriage as a shameful personal failure didn't arise until the 20th century.
Section: 1, Chapter: 2
Modern processed food has systematically undermined our natural feeling of satiety (fullness), driving overconsumption and obesity. Now Ozempic and similar drugs act to artificially boost satiety by mimicking natural gut hormones. In essence, an artificial solution (drugs) is correcting an artificial problem (broken satiety caused by processed foods).
"Obesity is an artificial problem in the sense that [we now eat] highly energy-dense foods that normally [don't exist] in nature...And now we've come up with an artificial solution, which is to fix the artificially undermined satiety through an artificially designed drug." - Michael Lowe, hunger and obesity researcher.
He argues we should focus on fixing the unnatural food environment rather than resorting to drugs.
Section: 1, Chapter: 3
Ozempic and similar drugs were initially thought to work solely in the gut to increase satiety. But new research suggests they also act powerfully on the brain, potentially boosting self-control across the board. Key findings include:
- GLP-1 receptors are found extensively in the brain's appetite and reward centers
- Stimulating these receptors in rats reduced cravings for junk food but not healthy chow
- The drugs also reduced cravings for cocaine, alcohol, nicotine in rats - by up to 50%
- In human anecdotes, the drugs reduce addictive urges around alcohol, drugs, gambling
This raises fascinating questions - could obesity drugs help treat addiction and impulsive behavior more broadly? Are we on the cusp of a self-control revolution?
Section: 1, Chapter: 7
The author outlines 12 potential risks associated with Ozempic and similar drugs:
- "Ozempic face" and "Ozempic butt" - rapid weight loss can leave facial skin and buttocks saggy
- Thyroid cancer - some evidence GLP-1 drugs may boost risk by 50-75%
- Pancreatitis - GLP-1 drugs linked to 9x higher risk of sometimes fatal pancreas inflammation
- Stomach paralysis - 3.7x higher risk of digestive tract "freezing"
- Loss of muscle mass, increasing frailty/fall risk in elderly
- Malnutrition from appetite suppression
- Risk of shortages for diabetes patients as weight loss use soars
- Off-brand, possibly contaminated versions proliferating as demand outstrips supply
- Depression/anhedonia if drugs "numb" pleasure from food and life
- Unknown long-term risks that may only emerge years later
- Suicidal thoughts - flagged as a potential risk by European regulators
- Potential developmental harms if used by pregnant women
Section: 1, Chapter: 5
Eating disorder experts are sounding the alarm about Ozempic. They warn the drug's staggering power to curb appetite is "rocket fuel" for those already prone to disordered eating. Key concerns include:
- Anorexia-prone people abusing the drug to achieve dangerous thinness
- Ozempic disrupting hard-won progress in intuitive eating and body acceptance
- Inability to recover natural hunger cues after Ozempic dependence
- Slippery line between "legitimate" medical use and eating disorder abuse
With Ozempic, the age-old pressure for women to shrink themselves now has a new chemical enforcer. As one expert put it: "Dieting is out, while elimination is in." Specialists fear an explosion of life-threatening eating disorders if the drug's use continues unchecked.
Section: 1, Chapter: 10
Individuals considering Ozempic have to weigh two sets of serious risks - the well-established dangers of obesity (diabetes, heart disease, cancer, etc) vs the more uncertain risks of powerful new drugs. While these drugs seem to reduce obesity risks, they may carry risks of their own. There are no easy answers, but an honest consideration of this tradeoff is essential.
The author's friend Judy makes the case for taking Ozempic despite its risks and limitations. She compares it to her taking chemotherapy for cancer - an imperfect treatment made necessary by dire circumstances. While in an ideal world we'd solve obesity by fixing the food environment, Judy argues we have to act to save lives now with the tools available, even if they are artificial and risky. The house is already on fire - we can't wait for better building codes before putting it out.
Section: 1, Chapter: 3
Bariatric surgery, which reduces weight comparably to the new weight loss drugs, shows the power of substantial weight loss to improve health. In studies of severely obese people, in the 5 years after bariatric surgery:
- Diabetes disappeared in 75% of patients
- Hypertension resolved in 60%
- Risk of dying from diabetes fell 92%
- Risk of cancer death fell 60%
- Risk of heart disease death fell 56%
- Overall mortality risk fell 40%
This suggests if Ozempic can reverse obesity, it may dramatically cut the risk of obesity-related disease and death as well.
Section: 1, Chapter: 4
If Ozempic works by dialing down the brain's reward centers, that raises troubling possibilities. Could it dull all pleasure and motivation, not just around unhealthy temptations? Might it cause a joyless, depressed mental state called anhedonia? There's no clear proof of this yet, but it's a legitimate concern that needs monitoring, especially given the staggering numbers of people jumping on these drugs. Users should be aware of this potential trade-off. Policymakers and drugmakers must consider the massive implications if tens of millions are walking around with pharmacologically numbed reward systems.
Section: 1, Chapter: 7
The dominant theory is that Ozempic curbs appetite by dialing down food rewards. But brain imaging suggests it may be more about dialing up food "anti-rewards":
- Normally fatty/sugary food triggers a big dopamine (reward chemical) spike
- Ozempic doesn't seem to numb this food "high" - dopamine still spikes
- But on Ozempic, the brain's "aversion centers" also light up intensely to fatty/sugary food
- These zones generate negative feelings - disgust, fear, anxiety, restraint
So Ozempic may not rob food of pleasure so much as pair that pleasure with equal and opposite pain - an "aversion signal" that overwhelms reward and drives behavior change.
Section: 1, Chapter: 7
With demand far exceeding supply of brand-name Ozempic, many are turning to unregulated, possibly dangerous alternatives:
- "Compound" drugs made in dubious labs, often overseas
- Drugs that are completely mislabeled and aren't semaglutide at all
- Drugs obtained without doctor oversight and used at improper doses Experts warn these carry completely unknown risks, from contamination to incorrect ingredients. But for many, it feels like the only accessible option.
This dilemma highlights systemic issues - an obesogenic food environment, sky-high brand-name drug prices, and lack of universal health coverage. Individuals will have to weigh risks carefully, but real solutions require systemic changes.
Section: 1, Chapter: 5
Over the past century, a series of "miracle" diet drugs have been hyped, only to later prove disastrous:
- 1930s: DNP, an industrial chemical, caused cataracts, blindness and cooking people from the inside at high doses
- 1940s-1970s: Amphetamines soared in popularity but caused addiction, psychosis and heart damage
- 1990s: Fen-phen was hailed as the "holy grail" but caused heart valve damage and lung disease, killing patients like 27-year-old Mary Linnen. Drug companies hid the risks and had to pay $12 billion in settlements.
This pattern of hype, then harm, raises crucial questions about the safety of Ozempic and whether it will be the next chapter in this dark saga.
Section: 1, Chapter: 5
Books about Medicine
Medicine
Philosophy
Life
Being Mortal Book Summary
Atul Gawande
In "Being Mortal," surgeon Atul Gawande argues that medicine must shift its focus from simply extending life to enabling well-being, especially for the elderly and terminally ill, by helping patients and families courageously face mortality and define what matters most in their final days.
Medicine
Science
History
Society
Everything is Tuberculosis Book Summary
John Green
Tuberculosis has been entwined with humanity for millennia. Once romanticized as a malady of poets, today tuberculosis is a disease of poverty that walks the trails of injustice and inequity we blazed for it.
Health
Feminism
Medicine
Politics
I'm Sorry for My Loss Book Summary
Rebecca Little, Colleen Long
"I'm Sorry for Your Loss" is a groundbreaking exploration of the cultural silence, medical myths, and legal quagmires surrounding miscarriage, stillbirth, and abortion in America, weaving together personal stories, historical context, and expert insights to envision a world where no one has to grieve alone.
Health
Medicine
Science
Nutrition
Magic Pill Book Summary
Johann Hari
In "The Magic Pill," Johann Hari takes readers on a deeply personal and rigorously researched journey into the complex world of obesity and the revolutionary new weight-loss drugs that promise to fight it, grappling with the profound ethical, societal, and scientific questions they raise about our relationship with food, health, and the future of our bodies.
